Tag: Aytu BioScience

March 14, 2017 Off

25 years research finds oxidative stress is a leading cause of damage to sperm function

Aytu BioScience, Inc., a specialty pharmaceutical company focused on products in the field of urology, today announced the publication of journal article describing the effectiveness …

February 10, 2017 Off

Aytu sales up by 47% from September for first ever $1M-plus sales quarter. Reduces net loss

By Dino Mustafić

Aytu BioScience, a drugmaker focused on urology products, has increased gross product sales by 47% from the quarter ended September 30, 2016 to the quarter ended December 31, 2016, from $925,000 to $1,358,000, getting its first ever $1M-plus quarter sales.